18.20
3.94%
-0.7244
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CAPR?
Forum
Prognose
Aktiensplit
Finanzdaten der Capricor Therapeutics Inc-Aktie (CAPR)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
59.41%
4.9069
|
12.09 | 6.1858 | 3.9175 | 2.9867 |
Operating Expenses
|
13.49%
15.17
|
13.37 | 13.05 | 11.66 | 11.17 |
Benefits Costs and Expenses |
14.40%
14.70
|
12.85 | - | - | 10.75 |
Costs And Expenses |
14.40%
14.70
|
12.85 | 13.05 | 11.66 | 10.75 |
Operating Income/Loss |
701.21%
-10.27
|
-1.2813 | -6.8646 | -7.7473 | -8.1847 |
Nonoperating Income/Loss |
9.12%
0.4718
|
0.5192 | 0.474 | 0.3807 | 0.4164 |
Income/Loss From Continuing Operations Before Tax |
1,185%
-9.7941
|
-0.7621 | 6.1858 | -7.3666 | -7.7683 |
Income/Loss From Continuing Operations After Tax |
1,185%
-9.7941
|
-0.7621 | -6.3906 | -7.3666 | -7.7683 |
Net Income/Loss
|
1,185%
-9.7941
|
-0.7621 | -6.3906 | -7.3666 | -7.7683 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
2,294%
31.35
|
1.3095 | 25.82 | 25.34 | 25.25 |
Diluted Average Shares |
2,294%
31.35
|
1.3095 | 25.82 | 25.34 | 25.25 |
Basic Earnings Per Share |
1,650%
-0.31
|
0.02 | -0.25 | -0.29 | -0.31 |
Diluted Earnings Per Share |
1,650%
-0.31
|
0.02 | -0.25 | -0.29 | -0.31 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):